Skip to main content

Animations

MJFF Publications

5671 - 5680 of 8818 Results
Title
Year
  • Year
  • 2018
  • 2014
  • 2012
  • 2013
  • 2025
  • 2011
  • 2016
  • 2018
  • 2015
  • 2024
  • Summary Details
    RESTRICTED
    Title: Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30391-0
    Citation Count: 97
  • Summary Details
    OPEN
    Title: RETRACTED: ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo
    Journal Name: Molecular Therapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1038/mt.2014.129
    Citation Count: 82
  • Summary Details
    RESTRICTED
    Title: Reinforcing properties of Pramipexole in normal and parkinsonian rats
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2012.08.005
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson′s disease
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brainres.2013.07.025
    Citation Count: 28
  • Summary Details
    RESTRICTED
    Title: Structure-based optimization and binding assays for discovery of tau PET radiotracers: synthesis and in vivo evaluation of [11C]Z-3272
    Journal Name: Canadian Journal of Chemistry
    Publisher: Canadian Science Publishing
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1139/cjc-2025-0058
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70039-4
    Citation Count: 655
  • Summary Details
    OPEN
    Title: A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals?
    Journal Name: Hippocampus
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hipo.22671
    Citation Count: 162
  • Summary Details
    OPEN
    Title: A Large-Scale Multi-ancestry Genome-wide Study Accounting for Smoking Behavior Identifies Multiple Significant Loci for Blood Pressure
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2018.01.015
    Citation Count: 153
  • Summary Details
    OPEN
    Title: Isolating Visual and Proprioceptive Components of Motor Sequence Learning in ASD
    Journal Name: Autism Research
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/aur.1537
    Best OA location URL: http://doi.org/10.1002/aur.1537
    Citation Count: 34
  • Summary Details
    OPEN
    Title: A data-driven model of disability progression in progressive multiple sclerosis
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae434
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.